Literature DB >> 32281550

Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.

Kenichi Horisawa1, Atsushi Suzuki1.   

Abstract

Cells of multicellular organisms have diverse characteristics despite having the same genetic identity. The distinctive phenotype of each cell is determined by molecular mechanisms such as epigenetic changes that occur throughout the lifetime of an individual. Recently, technologies that enable modification of the fate of somatic cells have been developed, and the number of studies using these technologies has increased drastically in the last decade. Various cell types, including neuronal cells, cardiomyocytes, and hepatocytes, have been generated using these technologies. Although most direct reprogramming methods employ forced transduction of a defined sets of transcription factors to reprogram cells in a manner similar to induced pluripotent cell technology, many other strategies, such as methods utilizing chemical compounds and microRNAs to change the fate of somatic cells, have also been developed. In this review, we summarize transcription factor-based reprogramming and various other reprogramming methods. Additionally, we describe the various industrial applications of direct reprogramming technologies.

Entities:  

Keywords:  cell transplantation therapy; cell-fate conversion; direct reprogramming; industrial application; regenerative medicine; transcription factor

Mesh:

Year:  2020        PMID: 32281550      PMCID: PMC7247973          DOI: 10.2183/pjab.96.012

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  219 in total

1.  Heart regeneration in zebrafish.

Authors:  Kenneth D Poss; Lindsay G Wilson; Mark T Keating
Journal:  Science       Date:  2002-12-13       Impact factor: 47.728

2.  Direct Lineage Reprogramming Reveals Disease-Specific Phenotypes of Motor Neurons from Human ALS Patients.

Authors:  Meng-Lu Liu; Tong Zang; Chun-Li Zhang
Journal:  Cell Rep       Date:  2015-12-24       Impact factor: 9.423

3.  Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia.

Authors:  S Ferber; A Halkin; H Cohen; I Ber; Y Einav; I Goldberg; I Barshack; R Seijffers; J Kopolovic; N Kaiser; A Karasik
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming.

Authors:  Yang Zhou; Li Wang; Haley Ruth Vaseghi; Ziqing Liu; Rui Lu; Sahar Alimohamadi; Chaoying Yin; Ji-Dong Fu; Greg G Wang; Jiandong Liu; Li Qian
Journal:  Cell Stem Cell       Date:  2016-03-03       Impact factor: 24.633

5.  Reprogramming Mouse Cells With a Pancreatic Duct Phenotype to Insulin-Producing β-Like Cells.

Authors:  Takatsugu Yamada; Claudia Cavelti-Weder; Francisco Caballero; Philippe A Lysy; Lili Guo; Arun Sharma; Weida Li; Qiao Zhou; Susan Bonner-Weir; Gordon C Weir
Journal:  Endocrinology       Date:  2015-04-02       Impact factor: 4.736

6.  Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors.

Authors:  Ruifeng Yang; Ying Zheng; Ling Li; Shujing Liu; Michelle Burrows; Zhi Wei; Arben Nace; Meenhard Herlyn; Rutao Cui; Wei Guo; George Cotsarelis; Xiaowei Xu
Journal:  Nat Commun       Date:  2014-12-16       Impact factor: 14.919

7.  High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.

Authors:  Yuanbiao Zhao; Pilar Londono; Yingqiong Cao; Emily J Sharpe; Catherine Proenza; Rebecca O'Rourke; Kenneth L Jones; Mark Y Jeong; Lori A Walker; Peter M Buttrick; Timothy A McKinsey; Kunhua Song
Journal:  Nat Commun       Date:  2015-09-10       Impact factor: 14.919

8.  Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate.

Authors:  Shima Rastegar-Pouyani; Niusha Khazaei; Ping Wee; Abdulshakour Mohammadnia; Moein Yaqubi
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

9.  SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.

Authors:  Marta Winiecka-Klimek; Maciej Smolarz; Maciej P Walczak; Jolanta Zieba; Krystyna Hulas-Bigoszewska; Blazej Kmieciak; Sylwester Piaskowski; Piotr Rieske; Dawid P Grzela; Ewelina Stoczynska-Fidelus
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  Reprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors.

Authors:  Tomas Koblas; Ivan Leontovyc; Sarka Loukotova; Lucie Kosinova; Frantisek Saudek
Journal:  Mol Ther Nucleic Acids       Date:  2016-05-17       Impact factor: 10.183

View more
  6 in total

Review 1.  Pioneer factors as master regulators of the epigenome and cell fate.

Authors:  Aurelio Balsalobre; Jacques Drouin
Journal:  Nat Rev Mol Cell Biol       Date:  2022-03-09       Impact factor: 113.915

Review 2.  Cellular reprogramming: Mathematics meets medicine.

Authors:  Gabrielle A Dotson; Charles W Ryan; Can Chen; Lindsey Muir; Indika Rajapakse
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-12-02

Review 3.  Direct Conversion to Achieve Glial Cell Fates: Oligodendrocytes and Schwann Cells.

Authors:  Wonjin Yun; Yong Jun Kim; Gabsang Lee
Journal:  Int J Stem Cells       Date:  2022-02-28       Impact factor: 2.500

4.  Induced hepatic stem cells maintain self-renewal through the high expression of Myc coregulated by TET1 and CTCF.

Authors:  Chen Wang; Xinlu Yu; Sai Ding; Yang Liu; Hongxia Zhang; Jingbo Fu; Bing Yu; Haiying Zhu
Journal:  Cell Biosci       Date:  2022-09-02       Impact factor: 9.584

Review 5.  Generation and Application of Directly Reprogrammed Endothelial Cells.

Authors:  Cholomi Jung; Jee Eun Oh; Sangho Lee; Young-Sup Yoon
Journal:  Korean Circ J       Date:  2022-09       Impact factor: 3.101

6.  Spidroin Silk Fibers with Bioactive Motifs of Extracellular Proteins for Neural Tissue Engineering.

Authors:  Veronica A Revkova; Konstantin V Sidoruk; Vladimir A Kalsin; Pavel A Melnikov; Mikhail A Konoplyannikov; Svetlana Kotova; Anastasia A Frolova; Sergey A Rodionov; Mikhail M Smorchkov; Alexey V Kovalev; Alexander V Troitskiy; Peter S Timashev; Vladimir P Chekhonin; Vladimir G Bogush; Vladimir P Baklaushev
Journal:  ACS Omega       Date:  2021-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.